Antista

Quick links to important sections

Antista

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Antista

Property Description
Active Ingredient Chlorphenamine (Chlorphenamine maleate)
Form Syrup, Tablet, Capsule, Oral Liquid
Pharmacological Class Antihistamine
Type Classification First-Generation, Sedating Agent
Origin Synthetic Alkylamine Derivative

The Foundational Identity: A First-Generation Antihistamine

Antista is a synthetic medicinal preparation whose active ingredient, Chlorphenamine, belongs to the pharmacological class of antihistamines. Chlorphenamine is a Histamine-1 Receptor Antagonist. It is specifically categorized as a first-generation agent, a classification recognized due to its unique ability to access the central nervous system. This property differentiates it from newer, second-generation compounds, establishing its particular action profile.

Composition and Available Forms (Syrup, Tablet)

The preparation is a single-ingredient product containing Chlorphenamine, most commonly formulated as the maleate salt. This monocomponent composition offers targeted relief for allergic symptoms without introducing other active ingredients, such as decongestants or pain relievers found in some combination medicines. Crucially, the compound is widely available for oral administration in various forms, including syrup or liquid—a factor that often makes it the preferred presentation for specific patient groups—as well as traditional tablets and capsules.

General Role in Allergic Relief

The general role of Chlorphenamine is to provide relief by counteracting the effects of histamine, a chemical messenger released by the body during an immune or allergic response. By blocking the H1-receptor binding sites, the compound helps to interrupt the sequence of events that leads to the physical manifestations of an allergic reaction. This defining action helps mitigate the general discomfort associated with exposure to common triggers, making the medicine effective in alleviating the discomfort caused by allergic reactions.

Regulatory References

  1. NIH
  2. MedlinePlus

What side effects are possible with Antista?

Possible Side Effects and Safety Information

Official regulatory documents classify the potential adverse reactions of Antista (Chlorphenamine) according to their frequency and the physiological system affected. As a first-generation antihistamine, the safety profile is characterized by effects on the central nervous system and anticholinergic activity.

Frequency-Classified Adverse Reactions

The most commonly documented side effects are linked to the medicine's sedating properties. Regulatory sources categorize effects as follows:

Classification Examples of Adverse Reactions
Very Common Drowsiness (Sedation), Dry mouth
Common Dizziness, Blurred vision, Difficulty passing urine (Urinary retention), Confusion
Rare/Very Rare Blood dyscrasias, Severe Hypersensitivity reactions, Convulsions

Key Safety Systems and Concerns

Adverse effects are grouped by System-Organ Classes, primarily involving Nervous System Disorders (e.g., sedation, confusion) and Gastrointestinal Disorders (e.g., dry mouth, nausea). Less frequently, the cardiovascular system (e.g., palpitations, tachycardia) and the blood and lymphatic system (e.g., agranulocytosis) may be involved, the latter being rare but classified as a serious adverse reaction in regulatory labeling.

Safety notes for specific groups are included in official documents. Older adults are cited as being more susceptible to certain effects, such as confusion and urinary retention. Furthermore, drowsiness is explicitly noted as being most pronounced at the start of treatment or following a dose increase, a pattern cited in regulatory texts. Official cautions also relate to pre-existing conditions, such as closed-angle glaucoma and the concurrent use of Monoamine Oxidase Inhibitors (MAOIs), which can intensify the medicine's effects.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of the active ingredient Chlorphenamine is associated with severe, potentially life-threatening systemic outcomes documented in official regulatory labeling. Immediate medical attention or contact with emergency services is required for any suspected overdose.

Documented Manifestations The official overdose profile is defined by effects on the Central Nervous System (CNS) and the cardiovascular system. CNS effects may present in two contrasting ways: sedation and somnolence that can progress to coma, or paradoxical excitation manifesting as restlessness, agitation, toxic psychosis, and convulsions (seizures). Other manifestations include characteristic anticholinergic signs like dilated pupils, dry mouth, and urinary retention, alongside fever and vomiting. Regulatory documentation notes that children and the elderly are particularly susceptible to these severe neurological effects, specifically the paradoxical excitation.

Severe Outcomes and Management Life-threatening outcomes explicitly listed in regulatory summaries include cardiovascular collapse, severe hypotension, life-threatening arrhythmias, and respiratory failure (apnoea). Due to these severe risks, management must be focused on providing symptomatic and supportive care; official regulatory documents confirm that no specific antidote is known for Chlorphenamine overdose. Procedures for supportive management may involve the administration of activated charcoal if recent ingestion is suspected, and specific agents like intravenous diazepam for treating convulsions.

Therapeutic Uses of Antista

Antista (Pheniramine) is a medication used in the management of allergic symptoms. Its primary purpose is to provide relief from common manifestations associated with seasonal allergies and other types of allergic reactions.

Antista may assist in mitigating symptoms such as a runny nose, sneezing, and watery, itchy eyes. It is also a therapeutic option for addressing skin-related allergic responses, including itching and rashes. The medication is utilized to support the management of these specific allergic conditions in individuals where such symptoms are present.

Quick Facts

  • Primary Use: Management of allergic conditions.
  • Relief Provided: May help with symptoms like sneezing, runny nose, and itching.
  • Therapeutic Domain: Addresses manifestations of upper respiratory and skin allergies.

Eligibility and Restrictions for Use

Who Can and Cannot Use Antista?

This section describes the official population eligibility rules for Antista (Chlorphenamine) as defined in regulatory documents.

Populations Contraindicated (Must Not Use)

Antista is contraindicated in patients with a known hypersensitivity to Chlorphenamine or similar antihistamines, or to any component of the formulation. Use is prohibited for individuals treated with Monoamine Oxidase Inhibitors (MAOIs) within the past fourteen days. Patients with conditions that may be aggravated by the drug’s properties, such as narrow-angle glaucoma, an acute asthma attack, or blockages in the stomach or intestines, must not use this medicine.


Age and Condition Restrictions

Age: The use of oral tablet formulations is not recommended for children under six years of age. Use in older (geriatric) patients requires caution due to an increased risk of neurological effects.

Organ and Comorbidity Restrictions: Use is restricted and requires caution in patients with severe hepatic impairment or severe renal impairment. Caution is also specified for patients with prostatic hypertrophy, epilepsy, and certain cardiovascular conditions.

Pregnancy and Lactation: Use during the third trimester of pregnancy is restricted. Antista is generally not recommended during lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section details the officially documented interaction patterns for Antista (Chlorphenamine), based strictly on government regulatory labeling.

Contraindicated and Major Pharmacodynamic Interactions

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is a formally documented contraindication. MAOIs intensify and prolong both the central nervous system (CNS) depressant and anticholinergic effects of Chlorphenamine. Due to this severe risk, a mandatory 14-day separation period must be observed; Antista must not be administered within 14 days of discontinuing MAOI therapy.

Use with alcohol and other CNS depressants (such as sedatives, hypnotics, and opioids) results in additive CNS depression and is advised against or restricted in official documentation. Similarly, co-administration with other anticholinergic drugs may lead to additive anticholinergic effects, including ototoxic medications which may mask symptoms of ototoxicity.

Pharmacokinetic Interactions and Special Populations

Chlorphenamine exhibits pharmacokinetic interactions, most notably the inhibition of Phenytoin metabolism, which may increase the risk of Phenytoin toxicity. Antista is metabolized by Cytochrome P450 enzymes, specifically CYP2D6 and CYP3A4. Therefore, co-administration with inhibitors or inducers of these enzymes may result in an altered exposure or clearance of Chlorphenamine. Regulatory documents also note that the risk of CNS and anticholinergic interactions is heightened in elderly patients, and caution is advised for individuals with severe hepatic impairment.

Mechanism of Action

How Antista Works

Antista's mechanism of action is defined by a dual pharmacological strategy, primarily involving antagonism of histamine receptors across the body alongside a secondary anticholinergic activity.

Modulating Peripheral H1 Signaling and Capillary Permeability

The core mechanism involves the molecule acting as an inverse agonist/antagonist at Histamine H1 Receptors located on cells outside the central nervous system. This molecular action suppresses the physiological response initiated by endogenous histamine, a key inflammatory mediator. By blocking H1 signaling, the drug prevents the histamine-induced increase in vascular permeability and vasodilation, thereby restricting the histamine-induced movement of fluid into the perivascular space and influencing the resulting changes in tissue volume. This engagement of the H1 pathway causes a shift in the signaling balance within the targeted physiological response.

Central H1 Antagonism and Arousal System Influence

Due to its lipophilic properties, the molecule readily crosses the blood-brain barrier, leading to a significant H1 receptor blockade within the Central Nervous System (CNS). The drug thus modulates the activity of processes driven by distinct signaling patterns in the hypothalamus, resulting in measurable physiological adjustments that cause the inhibition of the histaminergic arousal pathway.

Secondary Anticholinergic Mechanism and Secretion Control

A secondary yet relevant mechanistic domain involves the drug’s affinity for Muscarinic Cholinergic Receptors, where it acts as a competitive antagonist. This activity affects systems where the neurotransmitter acetylcholine dominates. By engaging mechanisms that modulate parasympathetic signal transmission, the drug reduces the cholinergic tone on exocrine glands, which causes a reduction in cholinergic signal-mediated glandular output.

Dosage and Administration Information

The administration of Antista (Chlorphenamine) follows standardized clinical guidelines. The primary route of administration is oral, supplied in immediate-release tablets, liquid/syrup, and extended-release forms. For acute clinical situations, the medicine is also available for parenteral delivery via intravenous (IV), intramuscular (IM), or subcutaneous (SC) injection.

Oral dosing regimens establish a maximum daily intake. For immediate-release tablets, the typical adult dose is 4 mg, which may be taken every four to six hours, but must not exceed 24 mg in a 24-hour period. The medication may be taken either with or without food.

Specific use instructions apply to ensure proper administration. Extended-release tablets and capsules are designed to be swallowed whole and must not be crushed, chewed, or broken, as this would compromise the release profile. When administering the liquid form, a calibrated measuring device must be used for accurate milliliter measurement of the dose.

For pediatric patients (6 to under 12 years), the dose is typically 2 mg every four to six hours, up to a maximum of 12 mg daily. Older adults are often administered a lower initial dose and have a reduced maximum daily limit compared to the standard adult regimen.

Recent Clinical Evidence

Research evidence / Overview of Studies for Antista

Evidence for Use in Allergic Rhinitis

Studies exploring the agent's characteristics when applied in research contexts involving symptoms of allergic rhinitis have included numerous Randomized Controlled Trials (RCTs). These short-term trials often compared the compound against either an inactive substance (placebo) or other agents in the same class. Studies focused on measuring subjective changes in symptoms over defined time intervals, particularly those outcomes related to physical discomfort such as frequent sneezing, a runny nose, nasal congestion, and itchy or watery eyes. The evidence describes symptom patterns, noting that the agent was studied to examine changes in the intensity of immediate allergic reactions measured in the skin (wheal and flare).

However, long-term outcomes for daily or extended use are not fully established, as the majority of formal key symptom studies were limited to short follow-up durations, typically lasting only a few weeks. This means there is limited information for long-term outcomes concerning the persistence of the measured effects over many months or years.


Evidence for Use in Urticaria and Allergic Skin Manifestations

Antista was evaluated in studies related to acute and chronic urticaria, which are conditions involving periods of heightened symptoms such as hives and intense itching. The research base includes Systematic Reviews and comparative RCTs that examined outcomes measured for urticaria. Researchers monitored patients using specific scoring systems, such as the Urticaria Activity Score (UAS), to assess outcomes related to physical discomfort, particularly the severity of pruritus (itching) and the size and number of wheals (hives).

Findings describe patterns observed in the studies related to initial symptom monitoring. Comparative evidence is lacking for large-scale, recent, dedicated RCTs focusing solely on Antista versus a placebo for urticaria, as the agent is often included in comparative trials against newer agents. The available research often concentrates on populations whose condition was considered difficult to control (refractory) by standard treatments, and findings for uncomplicated cases may be uncertain.


Key Limitations and Areas of Uncertainty

Research highlights several areas where the evidence for Antista is less established or where more study is needed. The primary limitation is that follow-up durations were limited in many of the key symptom studies. Comparative evidence is lacking in some areas, and sample sizes were modest in some of the older or more specialized studies, meaning findings describe group patterns, not personal outcomes. Data for certain groups, such as those with specific comorbid conditions or the very old, remain insufficient to draw definitive conclusions.

Key Studies & References

  1. Chlorpheniramine (Oral Route) - MedlinePlus Drug Information
  2. DailyMed Search: Chlorpheniramine Maleate (Official Regulatory Prescribing Information)

Frequently Asked Questions (FAQ)

Common questions about Antista (FAQ)

Q: Is Antista the same kind of drug as newer medicines for allergies?

A: Antista is described in official documents as a first-generation antihistamine. This class of drug is known for its ability to affect the central nervous system, which may cause drowsiness. Newer antihistamine medicines are often designed to focus their action outside the brain and generally do not share this sedating property.

Q: Why is Antista sometimes prescribed over other similar treatments?

A: The unique properties of this medicine, including its potential to cause sedation and its secondary anticholinergic activity, are the distinguishing features that determine its role. These pharmacological characteristics influence when a healthcare provider may select it compared to other agents.

Q: Are the side effects of Antista usually severe?

A: The most common adverse reactions listed in regulatory documents are related to sedation and are generally not classified as severe. However, official labeling does note that rare effects, such as blood dyscrasias (changes in blood cells), are classified as serious adverse reactions.

Q: Can Antista be split or crushed if I have trouble swallowing pills?

A: Official use instructions state that extended-release forms are not intended to be broken or crushed, as this would change how the medicine is released into the body. For immediate-release tablets, the ability to split depends on the specific product; only tablets that are marked with a score line are intended to be divided.

Q: Is Antista safe for people with kidney problems?

A: Regulatory guidance specifies that caution is required when this medicine is used in patients who have severe renal impairment (severe kidney problems). This is because the body's process for eliminating the medicine may be reduced in these individuals.

Q: Are people with liver issues allowed to use Antista?

A: Official guidance specifies that caution is required when the medicine is used in patients with severe hepatic impairment (severe liver problems). Since the drug is metabolized in the liver, individuals with severe impairment require careful evaluation.

Q: Does Antista interact with over-the-counter pain relievers like ibuprofen?

A: Regulatory documents list major contraindications with certain prescription medicines (like MAOIs) and caution against use with other Central Nervous System (CNS) depressants. Specific major warnings for common non-opioid pain relievers are generally not cited, but Official documents indicate that all concurrent use of medicines should be discussed with a healthcare provider.

Q: Does taking Antista mean I can't drive or operate machinery?

A: Official warnings state that marked drowsiness may occur due to the medicine's properties. Caution is advised regarding driving a motor vehicle or operating machinery, particularly until an individual is aware of how the medicine may influence their alertness.

Q: What are the most common reasons a doctor would prescribe Antista?

A: The regulatory labels list the medicine's use as temporarily relieving symptoms associated with hay fever or other upper respiratory allergies. This includes common issues such as sneezing, a runny nose, and itching of the nose, throat, or eyes.

Q: What happens if I forget to take Antista one day?

A: Official administration guidelines describe a standardized process for a missed dose: if a dose is missed, it may be taken as soon as it is remembered. If it is nearly time for the next scheduled dose, the missed dose is typically skipped. Regulatory documents advise against taking double or extra doses to compensate.

Q: How quickly does Antista typically start working after you begin taking it?

A: Studies and official information indicate that the medicine typically begins to take effect within an hour, with the maximal effect often observed around two hours after the administration of a dose.

Q: How long does the effect of one dose of Antista usually last?

A: The dosing frequency indicated on the regulatory label for the immediate-release tablet form is typically every four to six hours. This interval aligns with the expected general duration of the effect of a single dose.

Q: Is Antista known to cause weight gain or loss?

A: Weight gain or loss is not listed as a common, very common, or rare side effect in the official regulatory documents for the single-ingredient formulation of this medicine.

Q: Can Antista affect my sleep schedule?

A: Drowsiness (sedation) is the most common adverse reaction, which directly relates to the medicine's effect on the brain’s arousal pathway and can impact the wake-sleep cycle. Conversely, regulatory labels also note that excitability or nervousness may occur in some individuals, which could also affect sleep.

Q: Are there any common foods or drinks that should be avoided with Antista?

A: Official warnings advise against the concurrent consumption of alcoholic beverages. This is because alcohol, sedatives, and tranquilizers can increase the level of drowsiness caused by the medicine. No specific foods are routinely listed as having a major interaction.

Q: Is Antista available as a generic drug?

A: The active ingredient in this medicine, Chlorphenamine (chlorpheniramine maleate), is widely available as a generic drug. It is sold both under its chemical name and various brand names.

How should Antista be stored and disposed of?

How to Store and Dispose of Antista

Storage and disposal of Antista (Chlorphenamine maleate) must comply strictly with official regulatory guidelines to maintain its stability and ensure safety.

Storage Requirements

Antista must be stored at a controlled room temperature, typically between 20 C and 25 C (68 F and 77 F). The product must be kept in its original container, which should remain tightly closed, and be protected from excessive moisture and heat. Liquid formulations are specifically instructed to not freeze. As with all medicines, Antista must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Antista should be disposed of using a community drug take-back program. If a program is unavailable, the medicine must be mixed with an undesirable substance, sealed in a container, and placed in the household trash. Antista is not recommended for flushing down the toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Antista found in:

A-Z Index: